Optimax, the Laser Eye surgery specialists, have now introduced the new generation of iFS IntraLase Lasers to clinics throughout the UK.
The development will provide Optimax surgeons with unprecedented levels of control during the procedure, meaning better results for patients.
A quicker, safer procedure
This new development is a refinement of state of the art Intralase technology. The laser engine runs almost 3 times faster, resulting in a quicker procedure – meaning the cornea is exposed for the shortest possible period, ensuring the best possible result.
Better results for active people
For those with an active lifestyle there is the added bonus of flap stability. Lasik procedures have so far carried an element of risk of flap movement after the treatment. This risk is removed owing to an improved technique for creating the flap.
Improvements to method used to create the flap means the process is now more rapid, with less pressure required and therefore less discomfort for the patient during the procedure.
Further technical refinements mean that complications which can lead to halos, glare and potential night vision problems are virtually eliminated.
“This is a great technical step forward for Optimax, meaning better vision outcomes than ever before. It shows our commitment to reviewing and updating our technology, offering laser eye surgery patients the most advanced procedures currently available,”, says Medical Director Malcolm Samuel.
Founded in 1991, Optimax is a laser eye surgery specialist with 23 clinics across the UK.
It is the only specialist UK laser eye surgery clinic chain, with expertise gained from more than 300,000 treatments. Its recent GBP £5m investment in the latest technology means that more people than ever are achieving 20:20 vision.
For further information, please contact:
James Seton, Marketing and Communications, Optimax
Tel: 020 7317 8639
This press release was distributed by ResponseSource Press Release Wire on behalf of Optimax Clinics Ltd in the following categories: Health, Sport, Medical & Pharmaceutical, Media & Marketing, for more information visit https://pressreleasewire.responsesource.com/about.